Skip to content
10-Q

Quarterly Report

GFR PHARMACEUTICALS INC

0001437749-12-004796

← back to feed
Filed
May 10, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 8, 2012 42.08M sh
Stockholders Equity Q1 2012 · Mar 31, 2012 $8.88M
Stockholders Equity Q1 2012 · Dec 31, 2011 $8.52M
Current Liabilities Q1 2012 · Mar 31, 2012 $2.2M
Current Liabilities Q1 2012 · Dec 31, 2011 $2.28M
Total Liabilities Q1 2012 · Mar 31, 2012 $3.04M
Total Liabilities Q1 2012 · Dec 31, 2011 $3.12M
Current Assets Q1 2012 · Mar 31, 2012 $1.55M
Current Assets Q1 2012 · Dec 31, 2011 $1.09M
Total Assets Q1 2012 · Mar 31, 2012 $12.63M
Total Assets Q1 2012 · Dec 31, 2011 $12.33M
Capex Q1 2012 · Mar 31, 2011 $82.18K
Operating Cash Flow Q1 2012 · Mar 31, 2011 $370.77K
Cash And Equivalents Q1 2012 · Mar 31, 2011 $599.21K
Cash And Equivalents Q1 2012 · Dec 31, 2010 $300.72K
Sga Expense Q1 2012 · Mar 31, 2011 $332.03K
Net Income Q1 2012 · Mar 31, 2011 $318.13K
Operating Income Q1 2012 · Mar 31, 2011 $420.71K
Gross Profit Q1 2012 · Mar 31, 2011 $718.24K
Cost Of Revenue Q1 2012 · Mar 31, 2011 $214.78K